# STEGLUJAN
> **NDA209805** · New Drug Application · Sponsor: MSD SUB MERCK · Approved 2017-12-19
## Drug
- **FDA Application Number:** NDA209805
- **Application type:** New Drug Application
- **Brand name:** STEGLUJAN
- **Generic name:** ERTUGLIFLOZIN AND SITAGLIPTIN
- **Active ingredients:** ERTUGLIFLOZIN; SITAGLIPTIN PHOSPHATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MSD SUB MERCK
- **Manufacturer:** Merck Sharp & Dohme LLC
- **First approval:** 2017-12-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209805)
---
*MORVS · CC0 1.0*